Asthma Clinical Trial
Official title:
Dietary Intake, Allergy and Respiratory Diseases in European Adults From the GA2LEN Follow-up Survey
The Nutrition Study of the GA2LEN Follow-Survey was designed to investigate the association between usual dietary intake and allergic and respiratory outcomes in adults across Europe. Within this framework, a food frequency questionnaire (FFQ) was designed to ascertain usual dietary intake of 250 food items, which was translated into the languages of the participant centres. Information on daily intake of foods, nutrients, and flavonoids was derived.
Within the GA2LEN Follow-up Survey, the Nutrition Survey was aimed at assessing dietary
intake in adults across European countries and its association with various outcomes of
allergy and respiratory health. In absence of an internationally comparable dietary
questionnaire to ascertain usual dietary intake, a single and standardized food frequency
questionnaire (FFQ) was design to be used as a common instrument in all participant
countries. The FFQ is comprised of 32 food sections and 250 food items. The FFQ sections were
designed following the recommendations by the EFCOSUM Group, which facilitate international
comparisons of dietary intake. It also included several staple foods to capture locally
representative dietary intake.
Participants reported how often they had consumed each of the foods over the previous month,
using eight predefined options (rarely or never, 1-3 times per month, once, 2-4, or 5-6 times
per week, once, 2-3 times per day). Standard food portion sizes were used to quantify the
intake following the recommendations from the UK's Food Standards Agency. Daily intake of
foods (g) were estimated and macro- and micronutrient and flavonoid intakes were derived. The
GA2LEN FFQ was validated in five EU countries, namely Finland, UK, Portugal, Germany, Poland,
and Greece, and demonstrated to be a good tool to assess mid-term intake of foods,
specifically essential polyunsaturated fatty acids (PUFAs). The instrument has also been
demonstrated to be an accurate tool to assess dietary sources of flavonoids.
Various approaches were planned to derive dietary exposures and to examine their association
with respiratory and allergic outcomes. These included the use of dietary patterns derived
from Principal Component Analysis (PCA), a dietary inflammatory index (DII), as well as
single antioxidants, and individual food items.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|